PGK1 Antikörper (AA 117-145)
Kurzübersicht für PGK1 Antikörper (AA 117-145) (ABIN3032224)
Target
Alle PGK1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 117-145
-
Verwendungszweck
- PGK1 Antibody
-
Kreuzreaktivität (Details)
- Expected species reactivity: Primate, Rat
-
Aufreinigung
- Purified
-
Immunogen
- A portion of amino acids 117-145 from the human protein was used as the immunogen for this PGK1 antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Titration of the PGK1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the PGK1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- PGK1 (Phosphoglycerate Kinase 1 (PGK1))
-
Andere Bezeichnung
- PGK1
-
Hintergrund
- Also known as ATP:3-phosphoglycerate 1-phosphotransferase (EC 2.7.2.3), this major enzyme in glycolysis catalyzes the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate, generating one molecule of ATP. New blood vessel formation or angiogenesis is critical for tumor expansion and metastasis. Lay et al. (2000) showed that the plasmin reductase isolated from conditioned medium of fibrosarcoma cells is the glycolytic enzyme phosphoglycerate kinase. They concluded that phosphoglycerate kinase not only functions in glycolysis but is secreted by tumor cells and participates in the angiogenic process as a disulfide reductase.
-
UniProt
- P00558
-
Pathways
- Cellular Glucan Metabolic Process
Target
-